Defendant Name:
Chembio Diagnostics, Inc.
Defendant Type:
Public Company
Document Reference:
33-11163-s
Document Details
Legal Case Name
In the Matter of Chembio Diagnostics, Inc.
Document Name
SEC Charges Medical Test Manufacturer with Misrepresenting Performance of Covid-19 Test
Document Date
02-Mar-2023
Document Format
Administrative Proceeding
Allegation Type
Securities Offering
Document Summary
The SEC "announced settled charges against Chembio Diagnostics, Inc., a New York-based manufacturer of medical diagnostic tests, for making a false and misleading statement about the performance of its COVID-19 antibody test shortly before a securities offering in which it raised millions of dollars."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
Monetary Penalties:
Civil Penalty
Individual:
$500,000.00
Shared: